IS
IS · IS · IS-EU/1/15/1025/001-002
Evotaz
ATC J05AR15
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG*
CountryIS (IS)
ATC codeJ05AR15
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "J05AR15",
"marketed": false,
"strength": "300 mg/150 mg",
"ma_number": "EU/1/15/1025/001-002",
"substance": "Atazanavirum INN súlfat,Cobicistatum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í smitsjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "42198"
}Related drugs
Other records sharing ATC code J05AR15.
- PLEvotazBristol-Myers Squibb Pharma EEIG
- DKEvotazBristol-Myers Squibb Pharma EEIG
- CZEVOTAZBristol-Myers Squibb Pharma EEIG, Dublin
- FIEVOTAZBristol-Myers Squibb Pharma EEIG
- CZEVOTAZBristol-Myers Squibb Pharma EEIG, Dublin
- BEEvotaz 300 mg - 150 mgBristol-Myers Squibb Pharma
- IEEVOTAZ 300 mg/150 mg film-coated tabletsBristol-Myers Squibb Pharma EEIG
- NLEVOTAZ 300 mg/150 mg filmomhulde tablettenBristol-Myers Squibb Pharma EEIG
Access this data programmatically
Query Evotaz and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.